MetLife, Inc.
MET · NYSE
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $17 | $17 | $18 | $18 |
| % Growth | -1.7% | -6% | -1% | – |
| Cost of Goods Sold | $14 | $13 | $14 | $14 |
| Gross Profit | $3 | $5 | $5 | $5 |
| % Margin | 17.4% | 26.4% | 25.9% | 26.4% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $2 | $2 | $2 | $2 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $2 | $2 | $2 |
| Operating Expenses | $2 | $4 | $3 | $3 |
| Operating Income | $1 | $1 | $1 | $1 |
| % Margin | 7.2% | 5.7% | 7.4% | 7.5% |
| Other Income/Exp. Net | $0 | $0 | $0 | $0 |
| Pre-Tax Income | $1 | $1 | $1 | $1 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 5.3% | 4.2% | 5.2% | 6.9% |
| EPS | 1.23 | 1.04 | 1.29 | 1.79 |
| % Growth | 18.3% | -19.4% | -27.9% | – |
| EPS Diluted | 1.22 | 1.03 | 1.28 | 1.78 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $1 | $1 | $2 | $2 |
| % Margin | 8.8% | 7.3% | 8.8% | 8.9% |